Clinical Trial

To Evaluate the Safety and Efficacy of a Single-Use IVUS Ablation for Primary Hypertension

Recruiting
View on ClinicalTrials.gov →
Summary
This is a prospective, multicenter, blinded, randomized controlled clinical trial designed to evaluate the safety and efficacy of a single-use intravascular ultrasound ablation catheter and ultrasound ablation system in the treatment of primary hypertension.
Trial Details
NCT Number NCT07051811
Lead Sponsor Lepu Medical Technology (Beijing) Co., Ltd.
Conditions Essential Hypertension
Enrollment 213 participants
Start Date 2025-02-25
Primary Completion 2027-12-31 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-07-04